The Burden of Clinically Significant Bleeding, Thrombocytopenia and Platelet Transfusions in Myelodysplastic Syndromes

被引:0
|
作者
Cheok, Kathleen Pao Lynn [1 ]
Chhetri, Rakchha [2 ,3 ]
Wee, Li Yan A. [2 ,3 ]
Salvi, Arabelle [4 ]
Mcrae, Simon [1 ]
Roxby, David John [5 ]
Singhal, Deepak [1 ,2 ,6 ]
Hiwase, Devendra K. [1 ,2 ,6 ]
机构
[1] Royal Adelaide Hosp, Dept Haematol, Adelaide, SA, Australia
[2] South Australian Hlth & Med Res Inst, Precis Med Theme, Adelaide, SA, Australia
[3] Cent Adelaide Local Hlth Network, Dept Haematol, Adelaide, SA, Australia
[4] Royal Adelaide Hosp, Adelaide, SA, Australia
[5] Flinders Med Ctr, Transfus Serv, Adelaide, SA, Australia
[6] Univ Adelaide, Sch Med, Adelaide, SA, Australia
关键词
D O I
10.1182/blood-2019-125273
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
719
引用
收藏
页数:3
相关论文
共 50 条
  • [31] The incidence and impact of thrombocytopenia in myelodysplastic syndromes
    Kantarjian, Hagop
    Giles, Francis
    List, Alan
    Lyons, Roger
    Sekeres, Mikkael A.
    Pierce, Sherry
    Deuson, Robert
    Leveque, Josvph
    CANCER, 2007, 109 (09) : 1705 - 1714
  • [32] Platelet function in the myelodysplastic syndromes
    Mittelman, M
    Zeidman, A
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2000, 71 (02) : 95 - 98
  • [33] PLATELET SURVIVAL IN MYELODYSPLASTIC SYNDROMES
    EFIRA, A
    CAUCHIE, P
    RAUIS, M
    DEMAERTELAERE, E
    ACTA HAEMATOLOGICA, 1986, 76 (2-3) : 124 - 126
  • [34] Postoperative bleeding after dentoalveolar surgery in patients with thrombocytopenia-are prophylactic platelet transfusions necessary?
    Lundstrom, Johan
    Wiqvist, Samuel
    Jadersten, Martin
    Tollemar, Victor
    Legert, Karin Garming
    SUPPORTIVE CARE IN CANCER, 2024, 32 (10)
  • [35] What is clinically significant bleeding?
    Chai, Khai Li
    Wood, Erica M.
    TRANSFUSION, 2021, 61 (02) : 340 - 343
  • [36] THE RISKS OF THROMBOCYTOPENIA AND THE STANDARD USES OF PLATELET TRANSFUSIONS
    STRAUSS, RG
    PLASMA THERAPY & TRANSFUSION TECHNOLOGY, 1986, 7 (03): : 279 - 285
  • [37] FETAL PLATELET TRANSFUSIONS IN THE MANAGEMENT OF ALLOIMMUNE THROMBOCYTOPENIA
    WATERS, AH
    IRELAND, R
    MIBASHAN, RS
    MURPHY, MF
    MILLAR, DS
    CHAPMAN, JF
    METCALFE, P
    DEVRIES, LS
    RODECK, CH
    NICOLAIDES, KH
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 323 - 323
  • [38] ANTENATAL TREATMENT OF ALLOIMMUNE THROMBOCYTOPENIA WITH PLATELET TRANSFUSIONS
    KEKOMAKI, R
    AMMALA, P
    BOCK, J
    FLESLAND, O
    NORDHAGEN, R
    OLSSON, I
    ROGNERUD, H
    SHANWELL, A
    TAANING, E
    TERAMO, K
    WESTGREN, M
    WIKMAN, A
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1311 - 1311
  • [39] REFRACTORINESS TO PLATELET TRANSFUSIONS FOR THROMBOCYTOPENIA OF CENTRAL ORIGIN
    NOROL, F
    DOSQUET, P
    BASTIT, D
    BLAISE, D
    BIERLING, P
    IZNARD, F
    LAMY, T
    MARIE, JP
    MERCATELLO, A
    MICLEA, JM
    VEIL, A
    VICARIOT, M
    RENOM, P
    PRAJS, E
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 1995, 2 (01) : 37 - 45
  • [40] Platelet transfusions for critically ill patients with thrombocytopenia
    Lieberman, Lani
    Bercovitz, Rachel S.
    Sholapur, Naushin S.
    Heddle, Nancy M.
    Stanworth, Simon J.
    Arnold, Donald M.
    BLOOD, 2014, 123 (08) : 1146 - 1151